Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2006, p. 781-784, Vol. 50, No. 2
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.2.781-784.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Departamento de Bacteriología y Virología,1 Departamento de Biotecnología, Instituto de Higiene, Facultad de Medicina, Universidad de la República, 11600 Montevideo, Uruguay,2 Cátedra de Microbiología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, 1113 Buenos Aires, Argentina,3 Centro de Biología Molecular "Severo Ochoa," CSIC-UAM, Campus de Cantoblanco, 28049 Madrid, Spain4
Received 29 July 2005/ Returned for modification 1 September 2005/ Accepted 4 November 2005
A small (8.2-kb) ColE1 plasmid encoding TEM-144 (a new ß-lactamase with a ceftazidimase profile) was sequenced by a gene-walking strategy. The blaTEM allele was carried on a Tn2 element, disrupting a Rom protein gene. TEM-144 differs from TEM-1 by two mutations (R164C and E240K) and from the ceftazidime-hydrolyzing TEM-91 by one mutation (T182M).
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |